Department of Anesthesiology, Deyang People's Hospital, Deyang, 618000, China.
Department of Anesthesiology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, 100010, China.
Neurochem Res. 2024 Oct;49(10):2682-2698. doi: 10.1007/s11064-024-04205-w. Epub 2024 Jul 13.
Alzheimer's disease (AD) represents the most widespread neurodegenerative disorder, distinguished by a gradual onset and slow progression, presenting a substantial challenge to global public health. The mitochondrial-associated membrane (MAMs) functions as a crucial center for signal transduction and material transport between mitochondria and the endoplasmic reticulum, playing a pivotal role in various pathological mechanisms of AD. The dysregulation of mitochondrial quality control systems is considered a fundamental factor in the development of AD, leading to mitochondrial dysfunction and subsequent neurodegenerative events. Recent studies have emphasized the role of MAMs in regulating mitochondrial quality control. This review will delve into the molecular mechanisms underlying the imbalance in mitochondrial quality control in AD and provide a comprehensive overview of the role of MAMs in regulating mitochondrial quality control.
阿尔茨海默病(AD)是最常见的神经退行性疾病,其特点是发病缓慢、进展缓慢,对全球公共卫生构成重大挑战。线粒体相关膜(MAMs)作为线粒体和内质网之间信号转导和物质运输的关键中心,在 AD 的各种病理机制中发挥着关键作用。线粒体质量控制系统的失调被认为是 AD 发展的一个基本因素,导致线粒体功能障碍和随后的神经退行性事件。最近的研究强调了 MAMs 在调节线粒体质量控制中的作用。本综述将深入探讨 AD 中线粒体质量控制失衡的分子机制,并全面概述 MAMs 在调节线粒体质量控制中的作用。